A drug used by those with Alzheimer's to improve memory may soon provide comfort to women who suffer chronic migraines every month.

Dr. Andrew Charles of the UCLA Headache Research and Treatment Program said five percent of women have a headache more than 15 days per month and suffer from migraines three times more than men

The U.S. Food and Drug Administration has reportedly disapproved GlaxoSmithKline Plc's antidepressant gepirone ER for use in adults with major depression.

The United Kingdom-based company said the FDA labeled the drug as "not approvable" and it cannot be cleared for marketing in the U.S

Traumatic life events such as physical or sexual abuse can hasten progress of HIV and AIDS and related death, according to a study published by the University of North Carolina at Chapel Hill School of Medicine.

It is the first known study during the period of highly active antiretroviral therapy (HAART) to link psychological factors with faster mortality in the disease

A study by the University of Michigan and the Department of Veteran Affairs revealed that although veterans diagnosed with depression are not more likely to commit suicide than other civilian patients, there is a significant difference in the suicide rate for younger war veterans.

Recoding more than 800,000 veterans, the study has been identified as the largest and most comprehensive, as well as the first to include in its participants veterans from Iraq and Afghanistan, according to the New York Times

The U.S. Food and Drug Administration (FDA) on Wednesday added new warnings about dangerous side effects associated with a sleep-disorder pill made by Cephalon.

The federal authorities sent a letter to doctors warning that the government has received reports of life-threatening rashes and hallucinations in patients taking Provigil